Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study
- PMID: 30904777
- DOI: 10.1016/j.jad.2019.03.007
Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study
Abstract
Background: Few studies have examined the prevalence and correlates of subsyndromal and syndromal depressive symptoms (SSSD) among older adults with schizophrenia spectrum disorder. In this report, we examined the prevalence of SSSD and their associations with sociodemographic characteristics, clinical characteristics of schizophrenia, comorbidity, psychotropic medications, quality of life, functioning and mental health care utilization in a large, multicenter sample of older adults with schizophrenia spectrum disorder.
Methods: Data from the Cohort of individuals with Schizophrenia Aged 55 years or more (CSA) were used to examine the prevalence of SSSD, defined using the Center of Epidemiologic Studies Depression (CESD) scale. Clinical characteristics associated with SSSD were explored.
Results: Among 343 older adults with schizophrenia spectrum disorder, 78.1% had either subsyndromal (30.6%) or syndromal (47.5%) depressive symptoms. SSSD were independently associated with positive and negative symptoms, lower quality of life, non-late-onset psychosis, benzodiazepine use and urbanicity. There were no significant associations of SSSD with other sociodemographic characteristics and psychotropic medications, or with general medical conditions. We found no significant differences in the proportion of participants who were treated with antidepressants between those with syndromal depressive symptoms and those without depression (22.1% vs. 20.0%, p = 0.89). SSSD were not associated with higher mental health care utilization.
Limitations: Data were cross-sectional and depression was not evaluated with a semi-structured interview.
Conclusion: SSSD may be highly prevalent and under-assessed and/or undertreated among older adults with schizophrenia spectrum disorder. Our findings should alert clinicians about the need to assess systematically and regularly depression in this vulnerable population.
Keywords: Antidepressants; Antipsychotic; Depression; Depressive symptoms; Elderly; Older; Prevalence; Risk factors; Schizophrenia; Treatment.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
A Longitudinal Study of the Outcome and Associated Factors of Subsyndromal and Syndromal Depression in Community-Dwelling Older Adults with Schizophrenia Spectrum Disorder.Am J Geriatr Psychiatry. 2015 Sep;23(9):925-33. doi: 10.1016/j.jagp.2014.06.011. Epub 2014 Jul 2. Am J Geriatr Psychiatry. 2015. PMID: 25113720
-
Effects of depression and cognitive impairment on quality of life in older adults with schizophrenia spectrum disorder: Results from a multicenter study.J Affect Disord. 2019 Sep 1;256:164-175. doi: 10.1016/j.jad.2019.05.063. Epub 2019 May 28. J Affect Disord. 2019. PMID: 31176189
-
Depression in first-episode schizophrenia.Am J Psychiatry. 1993 Nov;150(11):1643-8. doi: 10.1176/ajp.150.11.1643. Am J Psychiatry. 1993. PMID: 8105706
-
Co-occurring depressive symptoms in the older patient with schizophrenia.Drugs Aging. 2008;25(8):631-47. doi: 10.2165/00002512-200825080-00002. Drugs Aging. 2008. PMID: 18665657 Free PMC article. Review.
-
Treatment of schizoaffective disorder and schizophrenia with mood symptoms.Am J Psychiatry. 1999 Aug;156(8):1138-48. doi: 10.1176/ajp.156.8.1138. Am J Psychiatry. 1999. PMID: 10450252 Review.
Cited by
-
The Candidate Schizophrenia Risk Gene Tmem108 Regulates Glucose Metabolism Homeostasis.Front Endocrinol (Lausanne). 2021 Oct 8;12:770145. doi: 10.3389/fendo.2021.770145. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34690937 Free PMC article.
-
Excess mortality and its causes among older adults with schizophrenia versus those with bipolar disorder and major depressive disorder: a 5-year prospective multicenter study.Eur Arch Psychiatry Clin Neurosci. 2025 Apr;275(3):595-605. doi: 10.1007/s00406-023-01752-1. Epub 2024 Jan 31. Eur Arch Psychiatry Clin Neurosci. 2025. PMID: 38294521
-
Depression severity mediates stigma and quality of life in clinically stable people with schizophrenia in rural China.BMC Psychiatry. 2023 Nov 11;23(1):826. doi: 10.1186/s12888-023-05355-x. BMC Psychiatry. 2023. PMID: 37951892 Free PMC article.
-
Metformin Enhances Antidepressant/Antipsychotic Combination Therapy of Schizophrenia With Comorbid Depression in a Murine Model.Front Neurosci. 2020 Jun 3;14:517. doi: 10.3389/fnins.2020.00517. eCollection 2020. Front Neurosci. 2020. PMID: 32581680 Free PMC article.
-
Prevalence, Influencing Factors, and Cognitive Characteristics of Depressive Symptoms in Elderly Patients with Schizophrenia.Neuropsychiatr Dis Treat. 2021 Dec 14;17:3645-3654. doi: 10.2147/NDT.S341297. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 34934317 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical